EUVIMEDEUVIMED entdecken
Crossref

SRS88 Patey Prize Entrant - Oxygenated hypothermic machine perfusion of older kidneys donated after circulatory death reduces cardiolipin release in perfusate and impacts certain clinical outcomes

Ella Hobbs, Sadr Shaheed, Cees van Kooten, Henri Leuvenink, Ina Jochmans, Maria Kaisar, Rutger Ploeg, M Letizia Lo Faro

British Journal of Surgery · 27.03.2026 · 113 (Supplement_2)

DOI: 10.1093/bjs/znag018.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 27.03.2026. Verfasst von Ella Hobbs und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitochondrial dysfunction and ischaemia-reperfusion injury correlate with poorer post transplant outcomes in kidney transplantation (Lo Faro, 2024). The COPE COMPARE trial showed that hypothermic oxygenated machine perfusion (HMPO2) of kidneys donated after circulatory death is safe, and improves graft survival compared to non-oxygenated hypothermic machine perfusion (HMP) (Jochmans, 2020). In this study we hypothesised this may be modulated by enhanced mitochondrial protection. We analysed perfusate cardiolipin, a mitochondrial damage-associated molecular pattern, to investigate whether HMPO2 reduces cardiolipin release and impacts post-transplant outcomes.

Methods

Perfusate samples from COMPARE (ISRCTN32967929) collected at the beginning (P1) and end (P3) of perfusion were selected from paired kidneys (that is one kidney received HMP and the other HMPO2), n = 20 donors. Fluorimetric analysis measured cardiolipin concentrations. Clinical outcomes including creatinine clearance, eGFR, and graft failure were noted at 3, 6 and 12-months.

Results

End-perfusion cardiolipin was significantly lower in the HMPO2 group (P = 0.049, n = 9) compared to HMP (n = 13) and concentrations significantly correlated with perfusion length. Higher overall cardiolipin correlated with lower 12-month eGFR (P = 0.039) but did not relate to serum creatinine levels or creatinine clearance at 3, 6 or 12-months. Finally, failed grafts (n = 3) associated with higher end-perfusion cardiolipin levels than functioning grafts at 12-months (n = 17, P = 0.006).

Conclusions

We show high end-perfusion cardiolipin concentrations impact certain clinical outcomes, particularly reduced eGFR, and increased rates of graft failure at 12-months. Lower cardiolipin concentrations in HMPO2 supports the benefit of using HMPO2 for kidney preservation and presents mitoDAMPs as a marker for assessing post-transplant organ injury.

Zitieren

APA

Hobbs, E., Shaheed, S., Kooten, C. V., Leuvenink, H., Jochmans, I., Kaisar, M., Ploeg, R., & Faro, M. L. L. (2026). SRS88 Patey Prize Entrant - Oxygenated hypothermic machine perfusion of older kidneys donated after circulatory death reduces cardiolipin release in perfusate and impacts certain clinical outcomes. British Journal of Surgery, 113(Supplement_2). https://doi.org/10.1093/bjs/znag018.008

Vancouver

Hobbs E, Shaheed S, Kooten CV, Leuvenink H, Jochmans I, Kaisar M, et al. SRS88 Patey Prize Entrant - Oxygenated hypothermic machine perfusion of older kidneys donated after circulatory death reduces cardiolipin release in perfusate and impacts certain clinical outcomes. British Journal of Surgery. 2026;113(Supplement_2). doi:10.1093/bjs/znag018.008

BibTeX
@article{Hobbs2026,
  author = {Hobbs, Ella and Shaheed, Sadr and Kooten, Cees van and Leuvenink, Henri and Jochmans, Ina and Kaisar, Maria and Ploeg, Rutger and Faro, M Letizia Lo},
  title = {SRS88 Patey Prize Entrant - Oxygenated hypothermic machine perfusion of older kidneys donated after circulatory death reduces cardiolipin release in perfusate and impacts certain clinical outcomes},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_2},
  doi = {10.1093/bjs/znag018.008}
}
Kostenlos starten →